Evidence map›Paper›PMID 37483251›Full record

ArticleACS omega2023

CanB, a Druggable Cellular Target in

Giulia Degiacomi, Beatrice Gianibbi, Deborah Recchia, Giovanni Stelitano, Giuseppina Ivana Truglio, Paola Marra, Alessandro Stamilla, Vadim Makarov, Laurent Robert Chiarelli, Fabrizio Manetti and 1 more

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giulia DegiacomiDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia 27100, Italy.
Beatrice GianibbiDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena 53100, Italy.
Deborah RecchiaDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia 27100, Italy.
Giovanni StelitanoDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia 27100, Italy.ORCID https://orcid.org/0000-0002-5219-4770
Giuseppina Ivana TruglioDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena 53100, Italy.
Paola MarraDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia 27100, Italy.
Alessandro StamillaDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia 27100, Italy.
Vadim MakarovBakh Institute of Biochemistry, Russian Academy of Science, Moscow 119071, Russia.ORCID https://orcid.org/0000-0001-8746-2694
Laurent Robert ChiarelliDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia 27100, Italy.ORCID https://orcid.org/0000-0003-0348-9764
Fabrizio ManettiDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena 53100, Italy.ORCID https://orcid.org/0000-0002-9598-2339
Maria Rosalia PascaDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia 27100, Italy.ORCID https://orcid.org/0000-0002-8906-4937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment against tuberculosis can lead to the selection of drug-resistant

Identifiers

PMID37483251
PMCPMC10357428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.